Superworth

Kewaunee Scientific price to free cash flow KEQU

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Nov 2, 2026
8.9×
10-year median
13.1×
Against its 10-year history
30th
percentile: 0 is its lowest day, 100 its highest
10-year range
5.1× to 387×
Peer median
12.0×

Kewaunee Scientific's price to free cash flow is 8.9× as of Nov 2, 2026.

That is below its ten-year median of 13.1×, lower than on 70% of days in the last ten years.

Over that time it ranged from 5.1× in Apr 2026 to 387× in Dec 2019.

The median for 8 medical instruments and supplies stocks of a similar size is 12.0×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far8.9×5.1×23.8×
202521.3×5.7×41.6×
202411.5×6.8×16.5×
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
202181.2×79.7×83.1×
202015.6×15.2×33.5×
201933.8×10.8×387×
201818.6×14.1×34.5×
201715.6×6.8×15.6×
201613.5×10.3×24.0×
201531.5×7.2×31.5×
20147.5×7.4×14.2×
20138.3×5.2×115×
20125.4×3.2×6.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Kewaunee Scientific's size, closest first, today.

CompanyPrice to free cash flow
KEQUKewaunee Scientific8.9×
APTAlpha Pro Tech9.6×
PDEXPro DEX17.3×
UTMDUtah Medical Products19.6×
NEPHNephrosn/m
INFUInfuSystem12.0×
EMBCEmbecta2.1×
TCMDTactile Systems Technology19.3×
MOVMovado10.0×
Peer median12.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Kewaunee Scientific

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.